血浆N末端脑利钠肽诊断早产儿动脉导管未闭的应用价值
被引量:3
摘要
动脉导管未闭(patent ductus arteriosus,PDA)在早产儿非常常见,若未及时诊断与处理,常可诱发和促进充血性心力衰竭、慢性肺疾病、颅内出血和坏死性小肠结肠炎等的发生和发展。胎龄越小、出生体重越低,PDA发生率就越高,早期诊断及评价导管开放对血流动力学的影响首选多普勒超声心动图,但效果常受到设备及操作者经验的限制。
出处
《中华围产医学杂志》
CAS
2010年第5期418-419,共2页
Chinese Journal of Perinatal Medicine
参考文献12
-
1Clyman RI.Patent ductus arteriosus in the premature infant//Taeusch HW,Ballard RA,Gleason CA.Avery's disease of the newborn.7th ed.Philadelphia:W.B.Saundcrs Company,2001:699-709. 被引量:1
-
2Blume ED,Canter CE,Spicer R,et al.Prospective single-arm protocol of carvedilol in children with ventricular dysfunction.Pediatr Cardiol,2006,27:336-342. 被引量:1
-
3Puddy VF,Amirmansour C,Williams AF,et al.Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus artcriosus in preterm infants.Clin Sci (Lond),2002,103:75-77. 被引量:1
-
4El-Khuffash AF,Amoruso M,Culliton M,et al.N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants:a prospective observational study.Arch Dis Child Fetal Neonatal Ed,2007,92:F421-422. 被引量:1
-
5Farombi-Oghuvbu I,Matthews T,Mayne PD,et al.N-terminal pro-B-type natriuretic peptide:a measure of significant patent ductus arteriosus.Arch Dis Child Fetal Neonatal Ed,2008,93:F257-F260. 被引量:1
-
6Nuntnarumit P,Khositseth A,Thanomsingh P.N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.J Perinatol,2009,29:137-142. 被引量:1
-
7Kluckow M,Evans N.Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation.J Pediatr,1995,127:774-779. 被引量:1
-
8Maisel AS,Krishnaswamy P,Nowak RM,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.N Engl J Med,2002,347:161-167. 被引量:1
-
9Ootaki Y,Yamaguchi M,Yoshimura N,et al.Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease.J Thorac Cardiovasc Surg,2003,126:1411-1416. 被引量:1
-
10Suda K,Matsumura M,Matsumoto M.Clinical implication of plasma natriuretic peptides in children with ventricular septal defect.Pediatr Int,2003,45:249-254. 被引量:1
同被引文献27
-
1Jones LJ,Craven PD,Attia J,et al.Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants[J].Archives of Disease in Childhood-Fetal and Neonatal Edition,2011,96(1):F45-F52. 被引量:1
-
2Malviya M,Ohlsson A,Shah S.Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants[J].Cochrane Database of Systematic Reviews,2013,3:CD003951. 被引量:1
-
3De Felice C,Bechelli S,Tonni G,et al.Systematic underestimation of oxygen delivery in ventilated preterm infants[J].Neonatology,2010,98(1):18-22. 被引量:1
-
4Bancalari E,Claure N,Gonzalez A.Patent ductus arteriosus and respiratory outcome in premature infants[J].Neonatology,2005,88 (3):192-201. 被引量:1
-
5Echtler K,Stark K,Lorenz M,et al.Platelets contribute to postnatal occlusion of the ductus arteriosus[J].Nature Medicine,2010,16 (1):75-82. 被引量:1
-
6Hamrick SE,Hansmann G.Patent ductus arteriosus of the preterm infant[J].Pediatrics,2010,125(5):1020-1030. 被引量:1
-
7邵肖梅,叶鸿瑁,丘小汕.实用新生儿科学[M].4版.北京:人民卫生出版社,2011:530-533. 被引量:1
-
8Gokmen T,Erdeve O,Altug N,et al.Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus[J].Journal of Pediatrics,2011,158 (4):549-554,e1. 被引量:1
-
9Hsu JH,Yang SN,Chen HL,et al.B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus[J].Journal of Pediatrics,2010,157(1):79-84. 被引量:1
-
10Westerlind A,Whlander H,Lindstedt G,et al.Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy[J].Acta Paediatrica,2004,93(3):340-345. 被引量:1
引证文献3
-
1黄锂新,吕勤,张若松.布洛芬口服液治疗早产儿动脉导管未闭中血浆N末端脑利钠肽的变化及意义[J].医学研究杂志,2014,43(9):94-97. 被引量:4
-
2伍志敏,陈芯夏,梁衡杰.超声心动图在心内膜弹力纤维增生症和川崎病心力衰竭患儿诊疗中的应用[J].海南医学,2017,28(1):99-101. 被引量:12
-
3郭立艳.布洛芬混悬液联合氢化可的松治疗早产儿动脉导管未闭的临床研究[J].现代药物与临床,2017,32(10):1929-1933. 被引量:9
二级引证文献25
-
1胡远英.超声心动图对川崎病诊断作用研究[J].现代医用影像学,2020,0(1):159-160. 被引量:1
-
2李迎欣.氢化可的松联合布洛芬治疗动脉导管未闭早产儿的效果[J].医学信息,2021,34(S01):128-129.
-
3车玲,彭华保,朱文军,黄芳,史文元,曾群.动脉导管未闭早产儿血N端脑钠肽前体水平变化及临床意义[J].中南医学科学杂志,2016,44(4):447-452. 被引量:7
-
4黄慧洁,崔树利,王志杰,姚芒,武彦秋,刘霞,王燕.N-端脑钠肽前体水平监测在早产儿动脉导管未闭诊断评估中的作用[J].重庆医学,2016,45(23):3258-3260. 被引量:10
-
5郑欧弟.口服布洛芬治疗早产儿动脉导管未闭的疗效及安全性分析[J].北方药学,2018,15(3):167-168. 被引量:5
-
6李蔚,高峻,彭晶.超声心动图诊断心内膜弹力纤维增生症和川崎病的应用研究[J].临床超声医学杂志,2018,20(11):735-739. 被引量:4
-
7钱磊,黄轩.口服布洛芬对早产儿动脉导管未闭治疗的效果观察[J].中国现代医生,2018,56(30):51-53. 被引量:4
-
8刘沧海,肖汇琼.布洛芬混悬液治疗小儿发热的效果及安全性分析[J].中国当代医药,2018,25(10):121-123. 被引量:14
-
9李蔚,高峻,彭晶.二维与三维斑点追踪成像技术在川崎病患儿左室收缩功能检测中的比较分析[J].临床超声医学杂志,2018,20(12):826-829. 被引量:8
-
10赖伟兰,朱细金,陈亚萍.早期补充维生素D对早产儿25-(OH)D、IgG、IgM、补体C3、补体C4的关联研究[J].标记免疫分析与临床,2018,25(12):1849-1852. 被引量:4
-
1王虹.多普勒超声心动图定位室间隔缺损的思路[J].深圳中西医结合杂志,2000,10(5):232-233. 被引量:1
-
2高怡,高云华,祝善俊.多普勒超声心动图在心脏起搏中的应用[J].中华超声影像学杂志,1995,4(1):38-40.
-
3高怡,高云华,杨浩.多普勒超声心动图(PDE)评价不同起搏方式对右心功能的影响[J].临床超声医学杂志,1996,7(2):80-82. 被引量:1
-
4张洁,李新明,丁萍,章志娟.多普勒超声心动图对经皮二尖瓣球囊成形术前后的疗效观察[J].医学理论与实践,1999,12(11):665-665.
-
5胡丹元,罗荣眉,余海英.口服布洛芬治疗早产儿动脉导管未闭45例疗效观察和护理[J].福建医药杂志,2007,29(5):164-165. 被引量:2
-
6张聪聪,程国强.早产儿动脉导管未闭治疗的进展[J].中华儿科杂志,2012,50(11):871-874. 被引量:4
-
7林发振.口服布洛芬治疗早产儿动脉导管未闭16例临床疗效观察[J].临床医学,2011,31(7):117-117. 被引量:1
-
8刘永锋.BNP、TnT和TnI水平对预测重症脓毒症和脓毒症休克患者预后的临床意义[J].中国医药科学,2014,4(7):66-67. 被引量:4
-
9朱云利,马振,李强盛.脾肾阳虚型糖尿病肾病患者脑利钠肽、尿白蛋白排泄率的相关性探讨[J].中国中医药现代远程教育,2013,11(13):12-13. 被引量:3
-
10陈志华,梅徽,李鹏飞.肌钙蛋白 I和脑利钠肽对感染性休克心肌损伤的临床价值[J].中国基层医药,2014,21(9):1390-1391. 被引量:2